$ 1,700.0
Quantity: 50 MG
Available on backorder
Description
Product name: Polyglutamine Q20
Catalog#: 1808169
Synonyms: Q20,(Gln)20,PolyQ20,
CAS NO.:2579.18
Sequence: QQQQQQQQQQQQQQQQQQQQ
M.W:
M.F.:C100H162N40O41
Purity: 90% by HPLC
Counter ion: Trifluoacetate
Format: Lyophilized powder
Description: Polyglutamine (polyQ) expansions in certain proteins account for nine neurodegenerative disorders including Huntington’s Disease (HD), Kennedy’s Disease (KD), spinal and bulbar muscular atrophy (SBMA), dentatorubral pallidoluysian atrophy (DRPLA) and spinocerebellar ataxias (SCA) types 1, 2, 3, 6, 7 and 17. Thus, to evaluate the molecular mechanisms leading to those diseases, suitable research tools such as synthetic polyglutamine peptides are required.
Compound ID:
Usage: For Scientific Research Use Only, Not for Human Use.
